What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Patients will take oral tablets of QLS1410 once daily (QD) for 12 weeks.”In the company’s words, NCT07927556 on ClinicalTrials.gov
- Tested for
- Uncontrolled Hypertension (3 trials), Hypertension (HTN), Primary Aldosteronism
- Main trialPhase 2
- “The goal of this clinical trial is to measure the efficacy and safety of QLS1410 in participants with uncontrolled hypertension (uHTN) or treatment-resistant hypertension (rHTN). The main objective is to compare the difference in systolic blood pressure(SBP) change from baseline at Week 12 of treatment between participants receiving QLS1410 tablets and participants receiving placebo tablets.”In the company’s words, NCT07489612 on ClinicalTrials.gov
Other drugs for Uncontrolled Hypertension
- BaxdrostatAstraZeneca · Phase 3
- BR1019Boryung Pharmaceutical Co., Ltd · Phase 3
- CagriSemaNovo Nordisk · Phase 3
- RalinepagUnited Therapeutics · Phase 3
- OrforglipronEli Lilly · Phase 3
- HCP1803-3Hanmi · Phase 3
Coming up3
- DecPhase 2 trial completes · ClinicalTrials.gov
- Apr 2027Phase 2 trial completes · ClinicalTrials.gov
- Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 10 NovNew trial: none to Phase 2 · ClinicalTrials.gov NCT07927556
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Enrolling by invitation | Dec 2026 | QLS1410 in Participants With Uncontrolled Hypertension | |
| Phase 2Not yet recruiting | Apr 2027 | Study of QLS1410 in the Treatment of Primary Aldosteronism. | |
| Phase 2Not yet recruiting | Dec 2027 | A Phase II Clinical Trial to Evaluate the Efficacy and Safety of QLS1410 Tablets in Patients With Uncontrolled Hypertension Who Are Receiving One or More Background Drug Treatments | |
| Phase 1Not yet recruiting | 7 Feb 2026 | A Food Effect Study of QLS1410 in Healthy Chinese Adults | |
| Phase 1Not yet recruiting | May 2026 | A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026